References

Citations

1. Tiefer L (2002). Beyond dysfunction: A new view of women's sexual problems. Journal of Sex and Marital Therapy, 28(Suppl 1): 225–232.

2. Baram DA (2007). Sexuality, sexual dysfunction, and sexual assault. In JS Berek, ed., Novak's Gynecology, 14th ed., pp. 313–349. Philadelphia: Lippincott Williams and Wilkins.

3. Basson R (2002). Women's sexual desire—Disordered or misunderstood? Journal of Sex and Marital Therapy, 28(Suppl 1): 17–28.

4. Alline KM, Johnson LE (2002). Sexuality. In RJ Ham et al., eds., Primary Care Geriatrics: A Case-Based Approach, 4th ed., pp. 427–436. St. Louis: Mosby.

5. Heiman JR (2002). Sexual dysfunction: Overview of prevalence, etiological factors, and treatments. Journal of Sex Research, 39(1): 73–79.

6. Phillips NA (2000). Female sexual dysfunction: Evaluation and treatment. American Family Physician, 62(1): 127–137.

7. Eyler AE (2000). Sexual function and dysfunction in women. In RE Rakel, ed., Saunders Manual of Medical Practice, 2nd ed., pp. 631–635. Philadelphia: W.B. Saunders.

8. Haessler A, Rosenthal MB (2007). Psychological aspects of obstetrics and gynecology. In AH DeCherney, L Nathan, eds., Current Diagnosis and Treatment Obstetrics and Gynecologic, 10th ed., pp. 1003–1024. New York: McGraw-Hill.

9. Lightner DJ (2002). Female sexual dysfunction. Mayo Clinic Proceedings, 77(7): 698–702.

10. North American Menopause Society (2005). The role of testosterone therapy in postmenopausal women: Position statement of the North American Menopause Society. Menopause, 12(5): 497–511.

11. Mayor S (2004). Pfizer will not apply for a licence for sildenafil for women. BMJ, 328(7439): 542.

12. Fourcroy JL (2003). Female sexual dysfunction: Potential for pharmacotherapy. Drugs, 63(14): 1445–1457.

13. Ito TY, et al. (2001). A double-blind placebo study of ArginMax, a nutritional supplement for enhancement of female sexual function. Journal of Sex and Marital Therapy, 27(5): 541–549.

14. Aung HH, et al. (2004). Alternative therapies for male and female sexual dysfunction. American Journal of Chinese Medicine, 32(2): 161–173.

15. Chu MC, Lobo RA (2004). Formulations and use of androgens in women. Mayo Clinic Proceedings, 79(Suppl): S3–S7.

16. Billups KL, et al. (2001). A new non-pharmacological vacuum therapy for female sexual dysfunction. Journal of Sex and Marital Therapy, 27(5): 435–441.

Other Works Consulted

• Potter J (2006). Female sexuality: Assessing satisfaction and addressing problems. In DC Dale, DD Federman, eds., ACP Medicine, section 16, chap. 22. New York: WebMD.

• Becker JV, Johnson BR (2003). Sexual dysfunctions. In RE Hales, SC Yudofsky, eds., Textbook of Clinical Psychiatry, 4th ed., pp. 749–757. Washington, DC: American Psychiatric Publishing.

• Dambro MR (2006). Sexual dysfunction in women. In Griffith's 5-Minute Clinical Consult, p. 1030. Philadelphia: Lippincott Williams and Wilkins.

• Goldstein I (2007). Urological management of women with sexual health concerns. In AJ Wein et al., eds., Campbell-Walsh Urology, 9th ed., vol. 1, pp. 863–889. Philadelphia: Saunders Elsevier.

• Gretchen ML (2007). Emotional aspects of gynecology. In MA Stenchever et al., eds., Comprehensive Gynecology, 5th ed., pp. 177–194. St. Louis: Mosby.